309 related articles for article (PubMed ID: 22285754)
1. Diagnosis and management of hereditary angioedema: an emergency medicine perspective.
Moellman JJ; Bernstein JA
J Emerg Med; 2012 Aug; 43(2):391-400. PubMed ID: 22285754
[TBL] [Abstract][Full Text] [Related]
2. Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.
Riedl M
Clin Ther; 2012 Mar; 34(3):623-30. PubMed ID: 22386830
[TBL] [Abstract][Full Text] [Related]
3. Overview of hereditary angioedema caused by C1-inhibitor deficiency: assessment and clinical management.
Bork K; Davis-Lorton M
Eur Ann Allergy Clin Immunol; 2013 Feb; 45(1):7-16. PubMed ID: 23678554
[TBL] [Abstract][Full Text] [Related]
4. Management of dental-oral procedures in patients with hereditary angioedema due to C1 inhibitor deficiency.
Jurado-Palomo J; Muñoz-Caro JM; López-Serrano MC; Prior N; Cabañas R; Pedrosa M; Burgueño M; Caballero T
J Investig Allergol Clin Immunol; 2013; 23(1):1-6. PubMed ID: 23653967
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of hereditary angioedema.
Canonica GW; Rossi O
Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
[TBL] [Abstract][Full Text] [Related]
6. Progress in the emergency management of hereditary angioedema: focus on new treatment options in the United States.
Bernstein JA; Moellman JJ
Postgrad Med; 2012 May; 124(3):91-100. PubMed ID: 22691903
[TBL] [Abstract][Full Text] [Related]
7. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency.
Bork K; Hardt J; Witzke G
J Allergy Clin Immunol; 2012 Sep; 130(3):692-7. PubMed ID: 22841766
[TBL] [Abstract][Full Text] [Related]
8. Hereditary angioedema: a decade of human C1-inhibitor concentrate therapy.
Farkas H; Jakab L; Temesszentandrási G; Visy B; Harmat G; Füst G; Széplaki G; Fekete B; Karádi I; Varga L
J Allergy Clin Immunol; 2007 Oct; 120(4):941-7. PubMed ID: 17761272
[TBL] [Abstract][Full Text] [Related]
9. Clinical Pattern and Acute and Long-term Management of Hereditary Angioedema Due to C1-Esterase Inhibitor Deficiency.
Gómez-Traseira C; Pérez-Fernández E; López-Serrano MC; García-Ara MC; Pedrosa M; López-Trascasa M; Caballero T
J Investig Allergol Clin Immunol; 2015; 25(5):358-64. PubMed ID: 26727765
[TBL] [Abstract][Full Text] [Related]
10. An evidence based therapeutic approach to hereditary and acquired angioedema.
Bork K
Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in the management of hereditary angioedema.
Hemperly SE; Agarwal NS; Xu YY; Zhi YX; Craig TJ
J Am Osteopath Assoc; 2013 Jul; 113(7):546-55. PubMed ID: 23843378
[TBL] [Abstract][Full Text] [Related]
12. A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).
Bork K
Clin Rev Allergy Immunol; 2016 Oct; 51(2):183-92. PubMed ID: 27207174
[TBL] [Abstract][Full Text] [Related]
13. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.
Farkas H; Csuka D; Gács J; Czaller I; Zotter Z; Füst G; Varga L; Gergely P
Clin Immunol; 2011 Oct; 141(1):58-66. PubMed ID: 21636327
[TBL] [Abstract][Full Text] [Related]
14. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
Kreuz W; Martinez-Saguer I; Aygören-Pürsün E; Rusicke E; Heller C; Klingebiel T
Transfusion; 2009 Sep; 49(9):1987-95. PubMed ID: 19497056
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks.
Bernstein JA; Ritchie B; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz DS; Obtulowicz K; Reshef A; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Schindel F; Craig TJ
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):149-54. PubMed ID: 20674826
[TBL] [Abstract][Full Text] [Related]
16. Hereditary Angioedema Due to C1-Inhibitor Deficiency in Romania: First National Study, Diagnostic and Treatment Challenges.
Gabos G; Nadasan V; Mihaly E; Dobru D
Iran J Immunol; 2020 Sep; 17(3):226-235. PubMed ID: 32996899
[TBL] [Abstract][Full Text] [Related]
17. Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema.
Nzeako UC; Longhurst HJ
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):353-61. PubMed ID: 22410711
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency.
Zanichelli A; Mansi M; Periti G; Cicardi M
Expert Rev Clin Immunol; 2013 May; 9(5):477-88. PubMed ID: 23634741
[TBL] [Abstract][Full Text] [Related]
19. Hereditary and acquired complement component 1 esterase inhibitor deficiency: a review for the hematologist.
Cicardi M; Johnston DT
Acta Haematol; 2012; 127(4):208-20. PubMed ID: 22456031
[TBL] [Abstract][Full Text] [Related]
20. Emergency treatment of acute attacks in hereditary angioedema due to C1 inhibitor deficiency: what is the evidence?
Longhurst HJ
Int J Clin Pract; 2005 May; 59(5):594-9. PubMed ID: 15857357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
